Suppression of postprandial hypertriglyceridemia in rats and mice by oolong tea polymerized polyphenols

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 4, 2007, Pages 971-976

  Toyoda Ono, Yoshiko ^a   Yoshimura, Makiko ^a   Nakai, Masaaki ^a   Fukui, Yuko ^a   Asami, Sumio ^a   Shibata, Hiroshi ^a   Kiso, Yoshinobu ^a   Ikeda, Ikuo ^b  

^a SUNTORY LTD   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Oolong tea; Polyphenol; Postprandial hypertriglyceridemia

Indexed keywords

OOLONG TEA; POLYPHENOLS; POSTPRANDIAL HYPERTRIGLYCERIDEMIA; TRIGLYCERIDE ABSORPTION;

DRUG PRODUCTS; FERMENTATION; PHENOLS; PLANTS (BOTANY); POLYMERIZATION; RATS;

DISEASE CONTROL;

CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; HYPERTRIGLYCERIDEMIA; LYMPHATIC SYSTEM; MALE; METABOLISM; MOUSE; PHYSIOLOGY; POSTPRANDIAL STATE; RAT; SPRAGUE DAWLEY RAT; TEA;

ANIMALS; CATECHIN; FLAVONOIDS; HYPERTRIGLYCERIDEMIA; LYMPHATIC SYSTEM; MALE; MICE; MICE, INBRED C57BL; PHENOLS; POSTPRANDIAL PERIOD; RATS; RATS, SPRAGUE-DAWLEY; TEA; TRIGLYCERIDES;

MUS; RATTUS;

EID: 34247467083     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60635     Document Type: Article

References (28)

1. Cheng, Q. K., and Chen, Z. M., "Tea and Health," Press of Chinese Agricultural Science, Beijing (1994).
2. Benzie, I. F., and Azeto, Y. T., Total antioxidant capacity of teas by the ferric reducing/antioxidant power assay. J. Agric. Food Chem., 47, 633-636 (1999).
3. Kurihara, H., Fukami, H., Toyoda, Y., Kageyama, N., Tsuruoka, N., Shibata, H., Kiso, Y., and Tanaka, T., Inhibitiory effect of oolong tea on the oxidative state of low density lipoprotein (LDL). Biol. Pharm. Bull., 26, 739-742 (2003).
4. Kurihara, H., Fukami, H., Koda, H., Tsuruoka, N., Sugiura, N., Shibata, H., and Tanaka, T., Effects of oolong tea on metabolism of plasma fat in mice under restraint stress. Biosci. Biotechnol. Biochem., 66, 1955-1958 (2002).
5. Kurihara, H., Fukami, H., Asami, S., Toyoda, Y., Nakai, M., Shibata, H., and Yao, X. S., Effects of oolong tea on plasma antioxidative capacity in mice loaded with restraint stress assessed using the oxygen radical absorbance capacity (ORAC) assay. Biol. Pharm. Bull., 27, 1093-1098 (2004).
6. Ohmori, Y., Ito, M., Kishi, M., Mizutani, H., Katada, T., and Konishi, H., Antiallegic constituents from oolong tea stem. Biol. Pharm. Bull., 18, 683-686 (2001).
7. Uehara, M., Sugiura, H., and Sakurai, K., A trial of oolong tea in the management of recalcitrant atopic dermatitis. Arch. Dermatol., 137, 42-43 (2001).
8. Kuroda, Y., and Hara, Y., Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res., 35, 69-97 (1999).
9. Ooshima, T., Minami, T., Aono, W., Izumitani, A., Sobue, D., Fujiwara, T., Kawabata, S., and Hamada, S., Oolong tea polyphenols inhibit experimental dental caries in SPF rats infected with mutans streptococci. Caries. Res., 27, 124-129 (1993).
10. Ooshima, T., Minami, T., Aono, W., Tamura, Y., and Hamada, S., Reduction of dental plaque deposition in humans by oolong tea extract. Caries. Res., 28, 146-149 (1994).
11. Hosoda, K., Wang, M. F., Liao, M. L., Chuang, C. K., Iha, M., Clevidence, B., and Yamamoto, S., Antihyperglycemic effect of oolong tea in type-2 diabetes. Diabetes Care, 26, 1714-1718 (2003).
12. Yang, T. T., and Koo, M. W., Hypocholesterolemic effects of Chinese tea. Pharmacol. Res., 35, 505-512 (1997).
13. Shimada, K., Kawarabayashi, T., Tanaka, A., Fukuda, D., Nakamura, Y., Yoshiyama, M., Takeuchi, K., Sawaki, T., Hosoda, K., and Yoshikawa, J., Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease. Diabetes Res. Clin. Pract., 65, 227-234 (2004).
14. Han, L. K., Takaku, T., Li, J., Kimura, Y., and Okuda, H., Anti-obesity action of oolong tea. Int. J. Obes., 23, 98-105 (1999).
15. Nakai, M., Fukui, Y., Asami, S., Toyoda-Ono, Y., Iwashita, T., Shibata, H., Mitsunaga, T., Hashimoto, F., and Kiso, Y., Inhibitory effects of polyphenols on pancreatic lipase in vitro. J. Agric. Food Chem., 53, 4593-4598 (2005).
16. Hara, Y., Moriguchi, S., Kusumoto, A., Nakai, M., Toyoda-Ono, Y., Abe, K., Ohta, H., Shibata, H., Kiso, Y., and Segawa, T., Suppressive effects of oolong tea polyphenol-enriched oolong tea on postprandial serum triglyceride elevation. Jpn. Pharmacol. Ther. (in Japanese), 32, 335-342 (2004).
17. Han, L. K., Kimura, Y., Kawashima, M., Takaku, T., Taniyama, T., Hayashi, T., Zheng, Y. N., and Okuda, H., Anti-obesity effects in rodents of dietary tea saponin, a lipase inhibitor. Int. J. Obes., 25, 1459-1464 (2001).
18. Han, L. K., Kimura, Y., and Okuda, H., Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int. J. Obes., 23, 174-179 (1999).
19. Ikeda, I., Hamamoto, R., Uzu, K., Imaizumi, K., Nagao, K., Yanagita, T., Suzuki, Y., Kobatashi, M., and Kakuda, T., Dietary gallate esters of tea catechin reduce deposition of visceral fat, hepatic triacylglycerol, and activities of hepatic enzymes related to fatty acid synthesis in rats. Biosci. Biotechnol. Biochem., 69, 1049-1053 (2005).
20. Karpe, F., Postprandial lipoprotein metabolism and atherosclerosis. J. Intern. Med., 246, 341-355 (1999).
21. Ikeda, I., Tsuda, K., Suzuki, Y., Kobayashi, M., Unno, T., Tomoyori, H., Goto, H., Kawata, Y., Imaizumi, K., Nozawa, A., and Kakuda, T., Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. J. Nutr., 135, 155-159 (2005).
22. Ikeda, I., Tomari, Y., and Sugano, M., Interrelated effects of dietary fiber and fat on lymphatic cholesterol and triglyceride absorption in rats. J. Nutr., 119, 1383-1387 (1989).
23. Fletcher, M. J., A colorimetric method for estimating serum triglycerides. Clin. Chim. Acta, 22, 393-397 (1968).
24. Leonhardt, M., Hrupka, B., and Langhans, W., New approaches in the pharmacological treatment of obesity. Eur. J. Nutr., 38, 1-13 (1999).
25. Hsu, T. F., Kusumoto, A., Abe, K., Hosoda, K., Kiso, Y., Wang, M. F., and Yamamoto, S., Polyphenol-enriched oolong tea increases fecal lipid excretion. Eur. J. Clin. Nutr., 60, 1330-1336 (2006).
26. Zheng, G., Sayama, K., Okubo, T., Juneja, L. R., and Oguni, I., Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo, 18, 55-62 (2004).
27. Sawynok, J., Pharmacological rationale for the clinical use of caffeine. Drugs, 49, 37-50 (1995).
28. Astrup, A., Breum, L., Toubro, S., Hein, P., and Quaade, F., The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet: a double blind trial. Int. J. Obes. Relat. Metab. Disord., 16, 269-277 (1992).